Preferred Name |
rifamycin SV |
Synonyms |
rifamycin SV, monosodium salt |
ID |
http://purl.bioontology.org/ontology/MESH/C023808 |
altLabel |
rifamycin SV, monosodium salt Aemcolo rifamycin Rifamycine Chibret rifamycin SV, sodium salt Rifocyna 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-H)-dione, 21-acetate R-75-1 Rifocina Otafa Rifacin Rifamicina Colirio |
cui |
C1528414 C0890787 C0139817 C4741581 C0140576 C1528412 C1528415 C1528413 C0890786 C0073371 |
HM |
D012294 |
Inverse of RB |
15105-92-7 14897-39-3 0 DU69T8ZZPA |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19800501 |
MeSH Frequency |
407 |
MMR |
20191030 |
notation |
C023808 |
PA |
D018501 |
prefLabel |
rifamycin SV |
RR |
6998-60-3 (rifamycin SV) 15105-92-7 (mono-Na salt) 14897-39-3 (unspecified Na salt) |
SC |
1 |
Scope Statement |
RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009 |
SRC |
J Int Med Res 1980;8(1):1 |
TERMUI |
T000982049 T111465 T616898 T111467 T345434 T111464 T345433 T616897 T111466 T616895 T616902 T616900 |
TH |
NLM (1980) FDA SRS (2013) USAN (1980) MX FR NLM (2020) ES |
tui |
T109 T195 T121 |